Phase I Trial of the Combination of Bortezomib and Clofarabine in Adults With Refractory Solid Tumors, Lymphomas, or Myelodysplastic Syndromes
Phase of Trial: Phase I
Latest Information Update: 03 May 2017
At a glance
- Drugs Bortezomib (Primary) ; Clofarabine (Primary)
- Indications Lymphoma; Myelodysplastic syndromes; Solid tumours
- Focus Adverse reactions
- 07 May 2016 Patients with myelodysplastic syndromes will also be included in the trial, hence official title also changed.
- 07 May 2016 Planned End Date changed from 1 Aug 2016 to 1 Aug 2018.
- 07 May 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Feb 2018.